These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25112279)

  • 1. Pharmacological inhibition of DGAT1 induces sebaceous gland atrophy in mouse and dog skin while overt alopecia is restricted to the mouse.
    Floettmann E; Lees D; Seeliger F; Jones HB
    Toxicol Pathol; 2015 Apr; 43(3):376-83. PubMed ID: 25112279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of sebaceous gland atrophy-sparing DGAT1 inhibitors.
    Muise ES; Zhu Y; Verras A; Karanam BV; Gorski J; Weingarth D; Lin HV; Hwa J; Thompson JR; Hu G; Liu J; He S; DeVita RJ; Shen DM; Pinto S
    PLoS One; 2014; 9(2):e88908. PubMed ID: 24558447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study.
    Denison H; Nilsson C; Kujacic M; Löfgren L; Karlsson C; Knutsson M; Eriksson JW
    Diabetes Obes Metab; 2013 Feb; 15(2):136-43. PubMed ID: 22950654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial.
    Denison H; Nilsson C; Löfgren L; Himmelmann A; Mårtensson G; Knutsson M; Al-Shurbaji A; Tornqvist H; Eriksson JW
    Diabetes Obes Metab; 2014 Apr; 16(4):334-43. PubMed ID: 24118885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin modulates the effects of acyl CoA:diacylglycerol acyltransferase deficiency on murine fur and sebaceous glands.
    Chen HC; Smith SJ; Tow B; Elias PM; Farese RV
    J Clin Invest; 2002 Jan; 109(2):175-81. PubMed ID: 11805129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACAT-selective and nonselective DGAT1 inhibition: adrenocortical effects--a cross-species comparison.
    Floettmann JE; Buckett LK; Turnbull AV; Smith T; Hallberg C; Birch A; Lees D; Jones HB
    Toxicol Pathol; 2013; 41(7):941-50. PubMed ID: 23427273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice.
    Tsuda N; Kumadaki S; Higashi C; Ozawa M; Shinozaki M; Kato Y; Hoshida K; Kikuchi S; Nakano Y; Ogawa Y; Furusako S
    PLoS One; 2014; 9(11):e112027. PubMed ID: 25405858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687).
    Barlind JG; Bauer UA; Birch AM; Birtles S; Buckett LK; Butlin RJ; Davies RD; Eriksson JW; Hammond CD; Hovland R; Johannesson P; Johansson MJ; Kemmitt PD; Lindmark BT; Morentin Gutierrez P; Noeske TA; Nordin A; O'Donnell CJ; Petersson AU; Redzic A; Turnbull AV; Vinblad J
    J Med Chem; 2012 Dec; 55(23):10610-29. PubMed ID: 23116186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin-induced alopecia is associated with sebaceous gland degeneration.
    Selleri S; Seltmann H; Gariboldi S; Shirai YF; Balsari A; Zouboulis CC; Rumio C
    J Invest Dermatol; 2006 Apr; 126(4):711-20. PubMed ID: 16470179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.
    Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE
    J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice.
    Chen HC; Farese RV
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):482-6. PubMed ID: 15569818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving data analysis of an Oral Lipid Tolerance Test toward the standard for the Oral Glucose Tolerance Test: Cross species modeling effects of AZD7687 on plasma triacylglycerol.
    Morentin Gutierrez P; Yates J; Nilsson C; Birtles S
    Pharmacol Res Perspect; 2019 Apr; 7(2):e00465. PubMed ID: 30899516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans.
    Maciejewski BS; LaPerle JL; Chen D; Ghosh A; Zavadoski WJ; McDonald TS; Manion TB; Mather D; Patterson TA; Hanna M; Watkins S; Gibbs EM; Calle RA; Steppan CM
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G958-69. PubMed ID: 23558010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sebaceous Gland Atrophy in Psoriasis: An Explanation for Psoriatic Alopecia?
    Rittié L; Tejasvi T; Harms PW; Xing X; Nair RP; Gudjonsson JE; Swindell WR; Elder JT
    J Invest Dermatol; 2016 Sep; 136(9):1792-1800. PubMed ID: 27312025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sebaceous gland atrophy due to seborrheic dermatitis in a patient with alopecia: A potential pitfall.
    Zengin S; Guthrie J; Zoumberos N; Hamza M; Shalin SC
    J Cutan Pathol; 2024 Jul; 51(7):513-517. PubMed ID: 38613429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release--potential insight into mechanism of action.
    Liu J; Gorski JN; Gold SJ; Chen D; Chen S; Forrest G; Itoh Y; Marsh DJ; McLaren DG; Shen Z; Sonatore L; Carballo-Jane E; Craw S; Guan X; Karanam B; Sakaki J; Szeto D; Tong X; Xiao J; Yoshimoto R; Yu H; Roddy TP; Balkovec J; Pinto S
    Obesity (Silver Spring); 2013 Jul; 21(7):1406-15. PubMed ID: 23671037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sebaceous gland abnormalities in fatty acyl CoA reductase 2 (Far2) null mice result in primary cicatricial alopecia.
    Sundberg JP; Shen T; Fiehn O; Rice RH; Silva KA; Kennedy VE; Gott NE; Dionne LA; Bechtold LS; Murray SA; Kuiper R; Pratt CH
    PLoS One; 2018; 13(10):e0205775. PubMed ID: 30372477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights from the asebia mouse: a molecular sebaceous gland defect leading to cicatricial alopecia.
    Stenn KS
    J Cutan Pathol; 2001 Oct; 28(9):445-7. PubMed ID: 11553309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure.
    Liu L; Trent CM; Fang X; Son NH; Jiang H; Blaner WS; Hu Y; Yin YX; Farese RV; Homma S; Turnbull AV; Eriksson JW; Hu SL; Ginsberg HN; Huang LS; Goldberg IJ
    J Biol Chem; 2014 Oct; 289(43):29881-91. PubMed ID: 25157099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of cyclohexane carboxylic acid head group containing isoxazole and thiazole analogs as DGAT1 inhibitors.
    Kandre S; Bhagat PR; Reddy MM; Dalal R; Dixit A; Deshmukh NJ; Anthony J; Bose J; Anupindi R; Sharma R; Gupte A
    Eur J Med Chem; 2014 May; 79():203-15. PubMed ID: 24735646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.